Immunogenicity 14847
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
LRRIQ1
Transcript ID
uc021rbo.1
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (1214 aa)
MRSKT
1
DCATP
6
DFVPE
11
PSPHD
16
LPMDE
21
HVLPD
26
DADIN
31
FGYCE
36
VEEKC
41
RQSFE
46
AWQEK
51
QKELE
56
DKEKQ
61
TLKAQ
66
RDREE
71
KQFQE
76
EEEKR
81
HCWMK
86
QFKVE
91
KKKLE
96
NIQKQ
101
EQDKM
106
NDELY
111
KEEKI
116
WKEKF
121
KQHEE
126
YIRNL
131
HLQME
136
EERTR
141
FKDQQ
146
EKEKN
151
SLLKQ
156
QNNAA
161
VKIQA
166
KYKAF
171
VAYQK
176
YGPII
181
KEQIE
186
SKKRK
191
AQEWK
196
EKEAK
201
IRQKE
206
EENRK
211
RLEEE
216
QRIKE
221
ERKKQ
226
KEEER
231
KRREK
236
EYEEK
241
KNIVK
246
QEREQ
251
LISKE
256
KIILR
261
EDASQ
266
QLIIS
271
SALKK
276
SGYNN
281
KHLSL
286
EDISN
291
DKGDI
296
AKNLV
301
DENSK
306
KQEDV
311
LLWLV
316
EESNM
321
KENVD
326
RQTIL
331
KESIQ
336
VKLKE
341
SISSQ
346
TILAD
351
FKMEE
356
KNENL
361
AKKRC
366
SEELV
371
KQERK
376
YENTD
381
NKTEL
386
GNSDL
391
KGNLK
396
EQFPL
401
QELKS
406
DAQKE
411
EKIMK
416
HVINE
421
NTGQK
426
TQIIL
431
GHNQE
436
ISEVK
441
TNEEQ
446
KIIKD
451
NQQKK
456
IQKVE
461
KEEIQ
466
EQNGL
471
LYKDK
476
DTLVI
481
SVKQR
486
SLSLT
491
SENSK
496
DVREN
501
VILQE
506
KEIYS
511
KSKEI
516
EENPK
521
DNAWN
526
SGIVI
531
FNTTD
536
TMINI
541
EGKRN
546
DQDYV
551
LGRHA
556
PCEGL
561
SNYNA
566
ESSMV
571
SKEVN
576
SLKSE
581
IRNIS
586
EKCHE
591
NAPEP
596
DSMTC
601
CVSES
606
TLLYS
611
IEERR
616
LAWIK
621
SFKPW
626
LEIFK
631
QNQQK
636
KIVRR
641
KRPVK
646
CPANM
651
TPALD
656
KLEIL
661
RCGPW
666
DTLQQ
671
VTTVT
676
FQDLP
681
GCVLS
686
TLAEC
691
TNLQF
696
LSLRR
701
CGLTS
706
LHSLS
711
NCKKL
716
KYIDA
721
QENHI
726
EAIEC
731
ENLEN
736
LCVVL
741
LNKNQ
746
LTSLH
751
GLDGC
756
TNIQC
761
LELSY
766
NKITR
771
IGYSF
776
FLEEK
781
LVDNA
786
GFCHH
791
LGTST
796
SYLSL
801
AQVWI
806
PTGLC
811
WSWIP
816
ITSLT
821
KNSDC
826
NFLIS
831
HLYWN
836
CGLES
841
LKNLQ
846
QLILD
851
HNQLI
856
NTKGL
861
CDTPT
866
IVYLD
871
CSHNH
876
LTDVE
881
GVENC
886
GLLQI
891
LKLQG
896
NYLSE
901
LPSLE
906
NLVLL
911
RELHL
916
DDNSI
921
STVEA
926
FSSYW
931
LPLLQ
936
NITIS
941
QNSLT
946
KIVPL
951
FHFVS
956
LEKLD
961
VSHNC
966
LSDLK
971
SAIKW
976
FDACY
981
SLHEL
986
SLTGN
991
PLLQE
996
TNWRD
1001
SLLKV
1006
LPALR
1011
ILNGN
1016
ILNSN
1021
SESRT
1026
EEHNQ
1031
LGSAG
1036
FLALC
1041
QSQIR
1046
EFNLL
1051
IENYI
1056
TGKGD
1061
VFTLD
1066
TAENL
1071
CHYFK
1076
KLMIL
1081
STEYR
1086
HAHER
1091
GDVTI
1096
TKKDE
1101
SEAQK
1106
NHLAP
1111
TNSDS
1116
TLQNG
1121
VFYSC
1126
AREGE
1131
PDSPD
1136
IPEKW
1141
MDSVS
1146
SHSPL
1151
SKSAT
1156
CENME
1161
GRHQE
1166
ILVCQ
1171
KREDS
1176
KASSI
1181
PTIRI
1186
PFKEV
1191
VMTNS
1196
LLRNH
1201
QNIEP
1206
SEKM
1211
Mutation Information
DNA mutation:
None
Peptide Range:
1135 ~ 1159
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"EPDSPDIPEKWMDSVSSHSPLSKSA
||||||||||||.||||||||||||
Mutant:
EPDSPDIPEKWMNSVSSHSPLSKSA"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) LRRIQ1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay